[1]
|
Keku Temitope, O., Dulal, S., Deveaux, A., Jovov, B. and Han, X.S. (2015) The Gastrointestinal Microbiota and Colorectal Cancer. American Journal of Physiology: Gastrointestinal and Liver Physiology, 308, G351-G363.
https://doi.org/10.1152/ajpgi.00360.2012
|
[2]
|
Montalban-Arques, A. and Scharl, M. (2019) Intestinal Microbiota and Colorectal Carcinoma: Implications for Pathogenesis, Diagnosis, and Therapy. EBioMedicine, 48, 648-655. https://doi.org/10.1016/j.ebiom.2019.09.050
|
[3]
|
Konturek, P.C., Haziri, D., Brzozowski, T., et al. (2015) Emerging Role of Fecal Microbiota Therapy in the Treatment of Gastrointestinal and Extra-Gastrointestinal Diseases. Journal of Physiology and Pharmacology, 66, 483-491.
|
[4]
|
Nayfach, S., Shi, Z.J., Seshadri, R., Pollard, K.S. and Kyrpides, N.C. (2019) New Insights from Uncultivated Genomes of the Global Human Gut Microbiome. Nature, 568, 505-510. https://doi.org/10.1038/s41586-019-1058-x
|
[5]
|
Marchesi, J.R., Adams, D.H., Fava, F., et al. (2015) The Gut Microbiota and Host Health: A New Clinical Frontier. Gut, 65, 330-339. https://doi.org/10.1136/gutjnl-2015-309990
|
[6]
|
Nagasaka, M., Sexton, R., Alhasan, R., Rahman, S., Azmi, A.S. and Sukari, A. (2020) Gut Microbiome and Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer: A Review. Critical Reviews in Oncology/Hematology, 145, Article ID: 102841. https://doi.org/10.1016/j.critrevonc.2019.102841
|
[7]
|
Ganal-Vonarburg, S.C. and Duerr, C.U. (2020) The Interaction of Intestinal Microbiota and Innate Lymphoid Cells in Health and Disease throughout Life. Immunology, 159, 39-51. https://doi.org/10.1111/imm.13138
|
[8]
|
雷中利, 黄燕. 肠道菌群失调在肝癌发生、发展和预防、治疗中的研究进展[J]. 肿瘤药学, 2020, 10(1): 16-20.
|
[9]
|
Ye, B.X., Stary, C.M., Li, X.J., et al. (2018) Engineering Chimeric Antigen Receptor-T Cells for Cancer Treatment. Molecular Cancer, 17, 32. https://doi.org/10.1186/s12943-018-0814-0
|
[10]
|
Shreiner, A.B., Kao, J.Y. and Young, V.B. (2015) The Gut Microbiome in Health and in Disease. Current Opinion in Gastroenterology, 31, 69-75. https://doi.org/10.1097/MOG.0000000000000139
|
[11]
|
Khan, M.A.W., Ologun, G., Arora, R., McQuade, J.L. and Wargo, J.A. (2020) Gut Microbiome Modulates Response to Cancer Immunotherapy. Digestive Diseases and Sciences, 65, 885-896. https://doi.org/10.1007/s10620-020-06111-x
|
[12]
|
Belcheva, A., Irrazabal, T., Robertson, S.J., et al. (2014) Gut Microbial Metabolism Drives Transformation of msh2-Deficient Colon Epithelial Cells. Cell, 158, 288-299. https://doi.org/10.1016/j.cell.2014.04.051
|
[13]
|
Singh, N., Gurav, A., Sivaprakasam, S., et al. (2014) Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis. Immunity, 40, 128-139.
https://doi.org/10.1016/j.immuni.2013.12.007
|
[14]
|
Dai, Z.W., Coker, O.O., Nakatsu, G., Wu, W.K.K., Zhao, L.Y., Chen, Z.G., Chan, F.K.L., Kristiansen, K., Sung, J.J.Y., Wong, S.H. and Yu, J. (2018) Multi-Cohort Analysis of Colorectal Cancer Metagenome Identified Altered Bacteria across Populations and Universal Bacterial Markers. Microbiome, 6, 70.
|
[15]
|
Ridlon, J.M., Devendran, S., Alves, J.M., et al. (2019) The “in Vivo Lifestyle” of Bile Acid 7α-Dehydroxylating Bacteria: Comparative Genomics, Metatranscriptomic, and Bile Acid Metabolomics Analysis of a Defined Microbial Community in Gnotobiotic Mice. Gut Microbes, 11, 381-404. https://doi.org/10.1080/19490976.2019.1618173
|
[16]
|
Mizutani, S., Yamada, T. and Yachida, S. (2020) Significance of the Gut Microbiome in Multistep Colorectal Carcinogenesis. Cancer Science, 111, 766-773. https://doi.org/10.1111/cas.14298
|
[17]
|
Drewes, J.L., Housseau, F. and Sears, C.L. (2016) Sporadic Colorectal Cancer: Microbial Contributors to Disease Prevention, Development and Therapy. British Journal of Cancer, 115, 273-280. https://doi.org/10.1038/bjc.2016.189
|
[18]
|
Komorowski, A.S. and Pezo, R.C. (2020) Untapped “-omics”: The Microbial Metagenome, Estrobolome, and Their Influence on the Development of Breast Cancer and Response to Treatment. Breast Cancer Research and Treatment, 179, 287-300. https://doi.org/10.1007/s10549-019-05472-w
|
[19]
|
陈菲, 梁婷婷, 吕铮, 李薇, 崔久嵬. 肠道微生态与肿瘤发生和发展关系的研究进展[J]. 肿瘤代谢与营养电子杂志, 2020, 7(1): 7-12.
|
[20]
|
Wei, M.-Y., Shi, S., Liang, C., Meng, Q.-C., Hua, J., Zhang, Y.-Y., Liu, J., Zhang, B., Xu, J. and Yu, X.-J. (2019) The Microbiota and Microbiome in Pancreatic Cancer: More Influential than Expected. Molecular Cancer, 18, Article No. 97. https://doi.org/10.1186/s12943-019-1008-0
|
[21]
|
Brennan, C.A. and Garrett, W.S. (2016) Gut Microbiota, Inflammation, and Colorectal Cancer. Annual Review of Microbiology, 70, 395-411. https://doi.org/10.1146/annurev-micro-102215-095513
|
[22]
|
Zmora, N., Levy, M., Pevsner-Fishcer, M. and Elinav, E. (2017) Inflammasomes and Intestinal Inflammation. Mucosal Immunology, 10, 865-883. https://doi.org/10.1038/mi.2017.19
|
[23]
|
Wei, M.Y., Shi, S., Liang, C., Meng, Q.C., Hua, J., Zhang, Y.Y., Liu, J., Zhang, B., Xu, J. and Yu, X.J. (2019) The Microbiota and Microbiome in Pancreatic Cancer: More Influential than Expected. Molecular Cancer, 18, 97.
https://doi.org/10.1186/s12943-019-1008-0
|
[24]
|
Serra, N., Di Carlo, P., Gulotta, G., d’Arpa, F., Giammanco, A., Colomba, C., Melfa, G., Fasciana, T. and Sergi, C. (2018) Bactibilia in Women Affected with Diseases of the Biliary Tract and Pancreas. A STROBE Guidelines-Adherent Cross-Sectional Study in Southern Italy. Journal of Medical Microbiology, 67, 1090-1095.
https://doi.org/10.1099/jmm.0.000787
|
[25]
|
Brennan, C.A. and Garrett, W.S. (2016) Gut Microbiota, Inflammation, and Colorectal Cancer. Annual Review of Microbiology, 70, 395-411. https://doi.org/10.1146/annurev-micro-102215-095513
|
[26]
|
Parkin, D.M. (2006) The Global Health Burden of Infection-Associated Cancers in the Year 2002. International Journal of Cancer, 118, 3030-3044. https://doi.org/10.1002/ijc.21731
|
[27]
|
Kostic, A.D., Chun, E., Robertson, L., Glickman, J.N., Gallini, C.A., Michaud, M., Clancy, T.E., Chung, D.C., Lochhead, P., Hold, G.L., El-Omar, E.M., Brenner, D., Fuchs, C.S., Meyerson, M. and Garrett, W.S. (2013) Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment. Cell Host Microbe, 14, 207-215. https://doi.org/10.1016/j.chom.2013.07.007
|
[28]
|
Gagnière, J., Raisch, J., Veziant, J., et al. (2016) Gut Microbiota Imbalance and Colorectal Cancer. World Journal of Gastroenterology, 22, 501-518. https://doi.org/10.3748/wjg.v22.i2.501
|
[29]
|
Uribe-Herranz, M., Rafail, S., Beghi, S., Gil-de-Gómez, L., Verginadis, I., Bittinger, K., Pustylnikov, S., Pierini, S., Perales-Linares, R., Blair, I.A., Mesaros, C.A., Snyder, N.W., Bushman, F., Koumenis, C. and Facciabene, A. (2020) Gut Microbiota Modulate Dendritic Cell Antigen Presentation and Radiotherapy-Induced Antitumor Immune Response. Journal of Clinical Investigation, 130, 466-479. https://doi.org/10.1172/JCI124332
|
[30]
|
Zhou, J. and Boutros, M. (2020) JNK-Dependent Intestinal Barrier Failure Disrupts Host-Microbe Homeostasis during Tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America, 117, 9401-9412.
https://doi.org/10.1073/pnas.1913976117
|
[31]
|
Wu, S., Rhee, K.J., Zhang, M., Franco, A. and Sears, C.L. (2007) Bacteroides fragilis Toxin Stimulates Intestinal Epithelial Cell Shedding and Gamma-Secretase-Dependent E-Cadherin Cleavage. Journal of Cell Science, 120, 1944-1952.
https://doi.org/10.1242/jcs.03455
|
[32]
|
Baffy, G. (2020) Gut Microbiota and Cancer of the Host: Colliding Interests. Advances in Experimental Medicine and Biology, 1219, 93-107. https://doi.org/10.1007/978-3-030-34025-4_5
|
[33]
|
刘光峨, 马虎. 非小细胞肺癌免疫治疗相关生物标记物的研究进展[J]. 山东医药, 2020, 60(13): 100-103.
|
[34]
|
Gopalakrishnan, V., Helmink, B.A., Spencer, C.N., Reuben, A. and Wargo, J.A. (2018) The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell, 33, 570-580.
https://doi.org/10.1016/j.ccell.2018.03.015
|
[35]
|
Iida, N., Dzutsev, A., Stewart, C.A., Smith, L., Bouladoux, N., Weingarten, R., Molina, D.A., Salcedo, R., Back, T., Cramer, S., Dai, R.M., Kiu, H., Cardone, M., Naik, S., Patri, A.K., Wang, E., Marincola, F.M., Frank, K.M., Belkaid, Y., Trinchieri, G. and Goldszmid, R.S. (2013) Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment. Science, 342, 967-970. https://doi.org/10.1126/science.1240527
|
[36]
|
Gopalakrishnan, V., Spencer, C.N., Nezi, L., et al. (2018) Gut Microbiome Modulates Response to Anti-PD-1 Immunotherapy in Melanoma Patients. Science, 359, 97-103.
|
[37]
|
Vétizou, M., Pitt, J.M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M.P., Duong, C.P., Poirier-Colame, V., Roux, A., Becharef, S., Formenti, S., Golden, E., Cording, S., Eberl, G., Schlitzer, A., Ginhoux, F., Mani, S., Yamazaki, T., Jacquelot, N., Enot, D.P., Bérard, M., Nigou, J., Opolon, P., Eggermont, A., Woerther, P.L., Chachaty, E., Chaput, N., Robert, C., Mateus, C., Kroemer, G., Raoult, D., Boneca, I.G., Carbonnel, F., Chamaillard, M. and Zitvogel, L. (2015) Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota. Science, 350, 1079-1084. https://doi.org/10.1126/science.aad1329
|
[38]
|
Ma, W., Mao, Q., Xia, W., Dong, G., Yu, C. and Jiang, F. (2019) Gut Microbiota Shapes the Efficiency of Cancer Therapy. Frontiers in Microbiology, 10, 1050. https://doi.org/10.3389/fmicb.2019.01050
|
[39]
|
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., et al. (2013) The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide. Science, 342, 971-976.
https://doi.org/10.1126/science.1240537
|
[40]
|
Daillère, R., Vétizou, M., Waldschmitt, N., Yamazaki, T., Isnard, C., Poirier-Colame, V., et al. (2016) Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity, 45, 931-943. https://doi.org/10.1016/j.immuni.2016.09.009
|
[41]
|
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., Chen, Y., Chen, H., Hong, J., Zou, W. and Fang, J.Y. (2017) Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell, 170, 548-563. https://doi.org/10.1016/j.cell.2017.07.008
|
[42]
|
Villéger, R., Lopès, A., Carrier, G., et al. (2019) Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? International Journal of Molecular Sciences, 20, 4584.
|
[43]
|
Cui, M., Xiao, H., Luo, D., Zhang, X., Zhao, S., Zheng, Q., Li, Y., Zhao, Y., Dong, J., Li, H., et al. (2016) Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity. International Journal of Molecular Sciences, 17, 1786. https://doi.org/10.3390/ijms17111786
|
[44]
|
Blair, I.A., Mesaros, C.A., Snyder, N.W., Bushman, F., Koumenis, C. and Facciabene, A. (2020) Gut Microbiota Modulate Dendritic Cell Antigen Presentation and Radiotherapy-Induced Antitumor Immune Response. Journal of Clinical Investigation, 130, 466-479. https://doi.org/10.1172/JCI124332
|
[45]
|
Hekmatshoar, Y., Saadat, Y.R., Khatibi, S.M.H., Ozkan, T., Vahed, F.Z., Nariman-Saleh-Fam, Z., Gargari, B.P., Sunguroglu, A. and Vahed, S.Z. (2019) The Impact of Tumor and Gut Microbiotas on Cancer Therapy: Beneficial or Detrimental? Life Sciences, 233, Article ID: 116680. https://doi.org/10.1016/j.lfs.2019.116680
|
[46]
|
薛越, 王青青. 肠道菌群与恶性肿瘤的研究进展[J]. 实用肿瘤杂志, 2016, 31(1): 9-13.
|
[47]
|
Gensollen, T., Iyer, S.S., Kasper, D.L. and Blumberg, R.S. (2016) How Colonization by Microbiota in Early Life Shapes the Immune System. Science, 352, 539-544. https://doi.org/10.1126/science.aad9378
|